Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: results of randomized, placebo-controlled first-in-human and first-in-patient trials
Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy
IGF-1 LR3 VS IGF DES 1,3 MOA (MECHANISM OF ACTION) AND HALF LIFE IGF-1 LR3 Mechanism of Action & Half-Life To get even better results than their parent IGF-1, IGF DES 1,3 and IGF-1 LR3 were used separately on animal subjects for trials
GLP-1 has also been shown to improve mitochondrial function, insulin resistance, reduce oxidative stress, and may decrease the risk of atherosclerosis, cardiovascular diseases as well as Alzheimers dementia
Useful in aging research, exploring NAD+ pathways and cell repair
US$ 29.76
US$ 24.23
US$ 25.59
US$ 29.61
US$ 25.24
US$ 20.27
US$ 21.86
